BIW-8137

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBIW-8137
Drug Alias Nameganglioside GD2-targeting mAb (BioWa)BIW-8137
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionDisialoganglioside GD2 inhibitors
TargetsDisialoganglioside GD2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiowa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiowa Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A